Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation.
about
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents.Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantatSirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis.A non-coding cationic lipid DNA complex produces lasting anti-leukemic effects.Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.Sirolimus in unmanipulated haploidentical cell transplantation.Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
P2860
Q34272554-3DDCC14D-535A-44D2-A2C8-6E474F588F44Q36548362-C6659055-7C1C-4457-A001-9AED0AB511DAQ36548370-2EC08657-82F7-45F7-A799-A3DDA32325B2Q36777485-34D3B484-C324-43DF-AF9F-C8B70A4B5875Q36862464-3AE7B4D7-56FC-4E54-8FFB-C7C51F92C45BQ37061969-CAEFC9CD-56F8-4881-B96A-C7711F4FCD2DQ37159533-8B84A008-0577-4803-9251-B7080DFE33D4Q37238884-573193D8-66F8-47F2-9D98-2C51CAD82A6FQ37247581-85D7966A-7742-4CAC-B51C-A49E9BB3D0DFQ37621636-5EDDD2DF-6EC1-47C6-9DF4-2A56E5FFB9C5Q38202155-D33C2BD8-5D4B-4BA6-90D5-B28FB29434E4Q39677634-C2F64771-14E2-41C8-976D-3FBA6FE2A385Q43198291-3B4DCF8F-3191-45B2-A8F7-C1B075BEE6C0Q46434557-D36CD4BD-7316-418A-B469-4222267A5A67Q50531641-FD744030-436A-42BA-BFD0-7BC1A7619F4E
P2860
Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Control of advanced and refrac ...... eic stem cell transplantation.
@en
Control of advanced and refrac ...... eic stem cell transplantation.
@nl
type
label
Control of advanced and refrac ...... eic stem cell transplantation.
@en
Control of advanced and refrac ...... eic stem cell transplantation.
@nl
prefLabel
Control of advanced and refrac ...... eic stem cell transplantation.
@en
Control of advanced and refrac ...... eic stem cell transplantation.
@nl
P2093
P2860
P1476
Control of advanced and refrac ...... eic stem cell transplantation.
@en
P2093
Christopher Ehmann
David F Claxton
Witold Rybka
P2860
P304
P356
10.1111/J.1365-2141.2005.05600.X
P407
P577
2005-07-01T00:00:00Z